Business Relations Table

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

BR-Relations: 468

From Domain	Role	To Domain	Path
web.cms.net.cn	>>isReferenceFrom	tickerhouse.com	/top-story/cms-867-hk-8a8-sg-ruxolitinib-phosphate-cream-obtained-china-nda-approval-becoming-the-first-and-only-targeted-drug-for-vitiligo-in-china-2/
web.cms.net.cn	>>isReferenceFrom	vistaheadlines.com	/2025/12/11/cms-867-8a8-nda-of-innovative-drug-y-3-for-injection-for-acute-ischemic-stroke-accepted-in-china/
web.cms.net.cn	>>isReferenceFrom	xbeedaily.com	/2023/05/30/china-medical-system-an-innovative-drug-ilumetri-tildrakizumab-injection-approved-for-marketing-in-china/
web.cms.net.cn	>>isReferenceFrom	us.tulsaheadlines.net	/press-release/2026-06-23/34104/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	pyrrhiantimes.com	/press-release/2026-06-23/34234/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	edubutter.com	/press-release/2026-06-23/34226/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	globe.thebakersfieldtribune.com	/press-release/2026-06-23/34127/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	nbc46news.com	/press-release/2026-06-23/33936/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	cw360news.com	/press-release/2026-06-23/34028/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	fox450.com	/press-release/2026-06-23/33970/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	inews247.com	/press-release/2026-06-23/34202/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	fourletterswiki.com	/press-release/2026-06-23/34189/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	asia.airnewswire.com	/press-release/2026-06-23/34157/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	medicalresearchtv.com	/press-release/2026-06-23/34004/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	newyork.uspostnow.com	/press-release/2026-06-23/34067/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	blownews.co.uk	/press-release/2026-06-23/33930/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	blowupgossip.com	/press-release/2026-06-23/34178/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	thescient.com	/press-release/2026-06-23/34222/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against
web.cms.net.cn	>>isReferenceFrom	rageweekly.com	/2026/06/23/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-worlds-first-bispecific-antibody-for-passive-immunization-against-rabies/
web.cms.net.cn	>>isReferenceFrom	totalcryptoguide.com	/press-release/2026-06-23/33943/cms-class-1-innovative-drug-silevimig-injection-approved-in-china-becoming-the-world-s-first-bispecific-antibody-for-passive-immunization-against

1 2 3 ... 24 Nächste

Business Relations Table - o4.fyi ()

BR-Editor

Domain-Statistiken für "web.cms.net.cn"

BR-Relations: 468